NOS2 and diabetes mellitus: Based on the above data showing that diabetes had induced femoral artery ultrastructural damage and that metformin appeared to inhibit femoral artery tissue levels of AGEs, ET-1, and iNOS, we then sought to determine whether metformin treatment could inhibit diabetes-induced LEAD.